{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T03:12:04Z","timestamp":1794107524840,"version":"4.8.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274034"],"award-info":[{"award-number":["82274034"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.lungcan.2024.107957","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T07:16:45Z","timestamp":1726643805000},"page":"107957","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Blood-brain barrier and blood-brain tumor barrier penetrating peptide-drug conjugate as targeted therapy for the treatment of lung cancer brain metastasis"],"prefix":"10.1016","volume":"196","author":[{"given":"Meng-Zhu","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan-Qun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun-Li","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ting","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.lungcan.2024.107957_b0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.lungcan.2024.107957_b0010","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejca.2020.03.006","article-title":"Systemic treatment of brain metastases in non-small cell lung cancer","volume":"132","author":"Page","year":"2020","journal-title":"Eur. J. Cancer"},{"issue":"9","key":"10.1016\/j.lungcan.2024.107957_b0015","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1200\/JCO.1988.6.9.1474","article-title":"Brain metastases in adenocarcinoma of the lung: frequency, risk groups, and prognosis","volume":"6","author":"S\u00f8rensen","year":"1988","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2024.107957_b0020","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0169-5002(98)00020-8","article-title":"Is it time to reevaluate our approach to the treatment of brain metastases in patients with non-small cell lung cancer?","volume":"20","author":"Kelly","year":"1998","journal-title":"Lung Cancer"},{"issue":"4","key":"10.1016\/j.lungcan.2024.107957_b0025","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0360-3016(96)00619-0","article-title":"Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials","volume":"37","author":"Gaspar","year":"1997","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"4","key":"10.1016\/j.lungcan.2024.107957_b0030","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrclinonc.2014.25","article-title":"Current approaches to the treatment of metastatic brain tumours","volume":"11","author":"Owonikoko","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2024.107957_b0035","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ctrv.2016.03.009","article-title":"The impact of brain metastasis on quality of life, resource utilization and survival in patients with non-small-cell lung cancer","volume":"45","author":"Peters","year":"2016","journal-title":"Cancer Treat. Rev."},{"issue":"12","key":"10.1016\/j.lungcan.2024.107957_b0040","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/nm.3407","article-title":"Development, maintenance and disruption of the blood-brain barrier","volume":"19","author":"Obermeier","year":"2013","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.lungcan.2024.107957_b0045","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrd.2015.21","article-title":"From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery","volume":"15","author":"Banks","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107957_b0050","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrn1824","article-title":"Astrocyte-endothelial interactions at the blood-brain barrier","volume":"7","author":"Abbott","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107957_b0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/joim.13440","article-title":"The influence of the blood-brain barrier in the treatment of brain tumours","volume":"292","author":"Rathi","year":"2022","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.lungcan.2024.107957_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2015.02.002","article-title":"Overcoming the blood-brain tumor barrier for effective glioblastoma treatment","volume":"19","author":"van Tellingen","year":"2015","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.lungcan.2024.107957_b0065","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jconrel.2022.03.019","article-title":"Enhanced BBB and BBTB penetration and improved anti-glioma behavior of Bortezomib through dual-targeting nanostructured lipid carriers","volume":"345","author":"Farshbaf","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.lungcan.2024.107957_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114115","article-title":"Nanomedicine for brain cancer","volume":"182","author":"Quader","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"45","key":"10.1016\/j.lungcan.2024.107957_b0075","doi-asserted-by":"crossref","first-page":"41889","DOI":"10.1021\/acsami.9b14046","article-title":"Blood-brain barrier- and blood-brain tumor barrier-penetrating peptide-derived targeted therapeutics for glioma and malignant tumor brain metastases","volume":"11","author":"Chen","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"28","key":"10.1016\/j.lungcan.2024.107957_b0080","doi-asserted-by":"crossref","first-page":"6832","DOI":"10.1016\/j.biomaterials.2011.05.064","article-title":"Dual targeting effect of Angiopep-2-modified, DNA-loaded nanoparticles for glioma","volume":"32","author":"Huang","year":"2011","journal-title":"Biomaterials"},{"issue":"28","key":"10.1016\/j.lungcan.2024.107957_b0085","doi-asserted-by":"crossref","first-page":"6898","DOI":"10.1016\/j.biomaterials.2012.06.050","article-title":"A brain-vectored angiopep-2 based polymeric micelles for the treatment of intracranial fungal infection","volume":"33","author":"Shao","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.lungcan.2024.107957_b0090","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.biomaterials.2018.06.024","article-title":"Biodegradable PEG-poly(\u03c9-pentadecalactone-co-p-dioxanone) nanoparticles for enhanced and sustained drug delivery to treat brain tumors","volume":"178","author":"Chen","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.lungcan.2024.107957_b0095","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.biomaterials.2014.10.007","article-title":"Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles","volume":"37","author":"Ruan","year":"2015","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.lungcan.2024.107957_b0100","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nnano.2017.54","article-title":"Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence","volume":"12","author":"Xue","year":"2017","journal-title":"Nat. Nanotechnol."},{"issue":"7803","key":"10.1016\/j.lungcan.2024.107957_b0105","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41586-020-2156-5","article-title":"LRP1 is a master regulator of tau uptake and spread","volume":"580","author":"Rauch","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.lungcan.2024.107957_b0110","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13024-022-00560-w","article-title":"LRP1 is a neuronal receptor for \u03b1-synuclein uptake and spread","volume":"17","author":"Chen","year":"2022","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107957_b0115","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1172\/JCI81108","article-title":"Endothelial LRP1 transports amyloid-\u03b2(1\u201342) across the blood-brain barrier","volume":"126","author":"Storck","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lungcan.2024.107957_b0120","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jconrel.2018.04.035","article-title":"A novel peptide ligand RAP12 of LRP1 for glioma targeted drug delivery","volume":"279","author":"Ruan","year":"2018","journal-title":"J. Control. Release"},{"issue":"30","key":"10.1016\/j.lungcan.2024.107957_b0125","doi-asserted-by":"crossref","first-page":"e1800316","DOI":"10.1002\/adma.201800316","article-title":"Protein toxin chaperoned by LRP-1-targeted virus-mimicking vesicles induces high-efficiency glioblastoma therapy in vivo","volume":"30","author":"Jiang","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.lungcan.2024.107957_b0130","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jconrel.2019.12.010","article-title":"Target delivering paclitaxel by ferritin heavy chain nanocages for glioma treatment","volume":"323","author":"Liu","year":"2020","journal-title":"J. Control. Release"},{"issue":"10","key":"10.1016\/j.lungcan.2024.107957_b0135","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/s43018-022-00416-8","article-title":"Multimodal integration of radiology, pathology and genomics for prediction of response to PD-(L)1 blockade in patients with non-small cell lung cancer","volume":"3","author":"Vanguri","year":"2022","journal-title":"Nat Cancer"},{"issue":"5","key":"10.1016\/j.lungcan.2024.107957_b0140","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.ccell.2023.03.018","article-title":"Genomic mapping of metastatic organotropism in lung adenocarcinoma","volume":"41","author":"Lengel","year":"2023","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.lungcan.2024.107957_b0145","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1038\/s41591-022-02047-z","article-title":"Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer","volume":"28","author":"Jee","year":"2022","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107957_b0150","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s13046-018-0886-0","article-title":"Mechanism of piR-DQ590027\/MIR17HG regulating the permeability of glioma conditioned normal BBB","volume":"37","author":"Leng","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"19","key":"10.1016\/j.lungcan.2024.107957_b0155","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1073\/pnas.1516524113","article-title":"In vivo metabolic labeling of sialoglycans in the mouse brain by using a liposome-assisted bioorthogonal reporter strategy","volume":"113","author":"Xie","year":"2016","journal-title":"PNAS"},{"issue":"3","key":"10.1016\/j.lungcan.2024.107957_b0160","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.tiv.2004.06.011","article-title":"In vitro models for the blood-brain barrier","volume":"19","author":"Garberg","year":"2005","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.lungcan.2024.107957_b0165","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.2147\/IJN.S258699","article-title":"Enhanced anti-brain metastasis from non-small cell lung cancer of osimertinib and doxorubicin co-delivery targeted nanocarrier","volume":"15","author":"Wang","year":"2020","journal-title":"Int. J. Nanomed."},{"issue":"23","key":"10.1016\/j.lungcan.2024.107957_b0170","doi-asserted-by":"crossref","first-page":"5818","DOI":"10.1158\/1078-0432.CCR-16-0064","article-title":"PI3K pathway inhibition achieves potent antitumor activity in melanoma brain metastases in vitro and in vivo","volume":"22","author":"Niessner","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"17","key":"10.1016\/j.lungcan.2024.107957_b0175","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1016\/j.devcel.2021.07.009","article-title":"Chromosomal instability accelerates the evolution of resistance to anti-cancer therapies","volume":"56","author":"Lukow","year":"2021","journal-title":"Dev. Cell"},{"issue":"17","key":"10.1016\/j.lungcan.2024.107957_b0180","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.devcel.2021.08.017","article-title":"Diversity in chromosome numbers promotes resistance to chemotherapeutics","volume":"56","author":"Shaikh","year":"2021","journal-title":"Dev. Cell"},{"issue":"1","key":"10.1016\/j.lungcan.2024.107957_b0185","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.trecan.2021.09.002","article-title":"Chromosomal instability and aneuploidy as causes of cancer drug resistance","volume":"8","author":"Lukow","year":"2022","journal-title":"Trends Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2024.107957_b0190","doi-asserted-by":"crossref","first-page":"e10377","DOI":"10.1002\/btm2.10377","article-title":"Nanoalbumin-prodrug conjugates prepared via a thiolation-and-conjugation method improve cancer chemotherapy and immune checkpoint blockade therapy by promoting CD8(+) T-cell infiltration","volume":"8","author":"Chen","year":"2023","journal-title":"Bioeng. Transl. Med."},{"issue":"10","key":"10.1016\/j.lungcan.2024.107957_b0195","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/oxfordjournals.annonc.a058736","article-title":"Paclitaxel (Taxol) concentrations in brain tumor tissue","volume":"5","author":"Heimans","year":"1994","journal-title":"Ann. Oncol."},{"issue":"9","key":"10.1016\/j.lungcan.2024.107957_b0200","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1172\/JCI0215451","article-title":"Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo","volume":"110","author":"Fellner","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"14","key":"10.1016\/j.lungcan.2024.107957_b0205","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411722","article-title":"Paclitaxel delivery to the brain for glioblastoma treatment","volume":"24","author":"AbdEl-Haq","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"10.1016\/j.lungcan.2024.107957_b0210","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1523\/JNEUROSCI.3442-16.2017","article-title":"Astrocytic LRP1 Mediates Brain A\u03b2 Clearance and Impacts Amyloid Deposition","volume":"37","author":"Liu","year":"2017","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.lungcan.2024.107957_b0215","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10071597","article-title":"Brain cancer chemotherapy through a delivery system across the blood-brain barrier into the brain based on receptor-mediated transcytosis using monoclonal antibody conjugates","volume":"10","author":"Tashima","year":"2022","journal-title":"Biomedicines"},{"issue":"84","key":"10.1016\/j.lungcan.2024.107957_b0220","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002230","article-title":"Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target","volume":"3","author":"Yu","year":"2011","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107957_b0225","doi-asserted-by":"crossref","first-page":"14582","DOI":"10.1038\/s41598-020-71286-2","article-title":"Characterization of basigin monoclonal antibodies for receptor-mediated drug delivery to the brain","volume":"10","author":"Christensen","year":"2020","journal-title":"Sci. Rep."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500224004914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500224004914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T12:37:19Z","timestamp":1728477439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500224004914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":45,"alternative-id":["S0169500224004914"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2024.107957","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood-brain barrier and blood-brain tumor barrier penetrating peptide-drug conjugate as targeted therapy for the treatment of lung cancer brain metastasis","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2024.107957","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107957"}}